FR2790958B1 - DETECTION IN A BIOLOGICAL SAMPLE OF THE HSI PROTEIN WHERE THE PROTEIN IS ASSOCIATED WITH MAMMARY CANCER - Google Patents

DETECTION IN A BIOLOGICAL SAMPLE OF THE HSI PROTEIN WHERE THE PROTEIN IS ASSOCIATED WITH MAMMARY CANCER

Info

Publication number
FR2790958B1
FR2790958B1 FR9909832A FR9909832A FR2790958B1 FR 2790958 B1 FR2790958 B1 FR 2790958B1 FR 9909832 A FR9909832 A FR 9909832A FR 9909832 A FR9909832 A FR 9909832A FR 2790958 B1 FR2790958 B1 FR 2790958B1
Authority
FR
France
Prior art keywords
protein
detection
biological sample
hsi
mammary cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9909832A
Other languages
French (fr)
Other versions
FR2790958A1 (en
Inventor
Pierre Casellas
Lafontaine Joelle Simony
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority to FR9909832A priority Critical patent/FR2790958B1/en
Publication of FR2790958A1 publication Critical patent/FR2790958A1/en
Application granted granted Critical
Publication of FR2790958B1 publication Critical patent/FR2790958B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR9909832A 1999-07-29 1999-07-29 DETECTION IN A BIOLOGICAL SAMPLE OF THE HSI PROTEIN WHERE THE PROTEIN IS ASSOCIATED WITH MAMMARY CANCER Expired - Fee Related FR2790958B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9909832A FR2790958B1 (en) 1999-07-29 1999-07-29 DETECTION IN A BIOLOGICAL SAMPLE OF THE HSI PROTEIN WHERE THE PROTEIN IS ASSOCIATED WITH MAMMARY CANCER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9909832A FR2790958B1 (en) 1999-07-29 1999-07-29 DETECTION IN A BIOLOGICAL SAMPLE OF THE HSI PROTEIN WHERE THE PROTEIN IS ASSOCIATED WITH MAMMARY CANCER

Publications (2)

Publication Number Publication Date
FR2790958A1 FR2790958A1 (en) 2000-09-22
FR2790958B1 true FR2790958B1 (en) 2005-03-25

Family

ID=9548648

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9909832A Expired - Fee Related FR2790958B1 (en) 1999-07-29 1999-07-29 DETECTION IN A BIOLOGICAL SAMPLE OF THE HSI PROTEIN WHERE THE PROTEIN IS ASSOCIATED WITH MAMMARY CANCER

Country Status (1)

Country Link
FR (1) FR2790958B1 (en)

Also Published As

Publication number Publication date
FR2790958A1 (en) 2000-09-22

Similar Documents

Publication Publication Date Title
DK1133352T3 (en) Biological assay technique
DE69629805D1 (en) BIOLOGICAL REAGENT BALL
WO2004025268A3 (en) Optical biosensors and methods of use thereof
DE60039796D1 (en) Complete hemoglobin concentration measurement
ATE179215T1 (en) 4,7-DICHLORFLUORESCEIN DYES AS MOLECULAR PROBE
FR2794231B1 (en) RECOGNITION PROBE
DE59609222D1 (en) Amperometric biosensor
CA2284817A1 (en) Method for determining the presence of mutated brca protein
WO2000043791A3 (en) Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
DE69940355D1 (en) PERMANENTLY IMPLANTABLE BLOOD VESSEL WITH TRANSDUCER
DE69840107D1 (en) glucose biosensor
WO2001018252A3 (en) Methods for disease detection
NO20032395L (en) Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
CY1108182T1 (en) MEASURES FOR DETERMINING THE PATHOLOGICAL TRANSFORMATION OF THE APP PROTEIN AND ITS APPLICATIONS
DE69800720D1 (en) Blood cell staining reagent
AU7336400A (en) Diagnostic assay for type 2 heparin-induced thrombocytopenia
AU5143099A (en) Protein fragment complementation assays for the detection of biological or drug interactions
DE69129417D1 (en) DETECTING THE SYNDECANITY IN BIOLOGICAL MATERIALS, LIKE TISSUES AND BODY LIQUIDS, TO INDICATE THE VICTIMAL CONVERSION OF CELLS
FR2790958B1 (en) DETECTION IN A BIOLOGICAL SAMPLE OF THE HSI PROTEIN WHERE THE PROTEIN IS ASSOCIATED WITH MAMMARY CANCER
DK0967495T3 (en) Agricultural combine with volumetric sensor
FR2790957B3 (en) DETECTION IN A BIOLOGICAL SAMPLE OF THE SRBP PROTEIN, WHICH PROTEIN IS ASSOCIATED WITH BREAST CANCER
IL147486A0 (en) Methods and reagents for determining the prognosis of cancer patients by measuring bag proteins
NO20032391D0 (en) Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
IT8921789A0 (en) REAGENT FOR THE RESEARCH AND DETERMINATION OF BILIRUBIN IN URINE.
ATE258686T1 (en) DETECTION, QUANTIFICATION AND CLASSIFICATION OF RAS PROTEINS IN BODY FLUID AND TISSUES

Legal Events

Date Code Title Description
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 17

ST Notification of lapse

Effective date: 20161130